Back
4Front Ventures Vs. Bright Minds Biosciences Industry Stock Comparison
Sell
39
FFNT.CX
4Front Ventures
Last Price:
0.03
Seasonality Move:
14.41%
Sell
33
DRUG.CX
Bright Minds Biosciences
Last Price:
53.27
Seasonality Move:
-19.1%
Sell
39
4Front Ventures (FFNT.CX)
is a Sell
Is 4Front Ventures a Buy, Sell or Hold?
- The current 4Front Ventures [FFNT.CX] share price is $0.03. The Score for FFNT.CX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- FFNT.CX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Bright Minds Biosciences (DRUG.CX)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
- The current Bright Minds Biosciences [DRUG.CX] share price is $53.33. The Score for DRUG.CX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- DRUG.CX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FFNT.CX Stock Price Chart
What is 4Front Ventures's stock price today?
-
The 4Front Ventures share price today is $0.03
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FFNT.CX is experiencing slight buying pressure.
DRUG.CX Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $53.33
The current trend is moderately bearish and DRUG.CX is experiencing selling pressure, which indicates risk of future bearish movement.
FFNT.CX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 38.08 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.03 - 0.05) | Sell |
| Bollinger Bands (100): | (0.04 - 0.1) | Sell |
DRUG.CX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.31 | Buy |
| Relative Strength Index (14 RSI): | 48.03 | Sell |
| Chaikin Money Flow: | -902 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.44 - 64.72) | Sell |
| Bollinger Bands (100): | (-4.27 - 55.29) | Buy |
FFNT.CX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.04 | Sell |
| 20-day SMA: | 0.04 | Sell |
| 50-day SMA: | 0.06 | Sell |
| 200-day SMA: | 0.1 | Sell |
| 8-day EMA: | 0.03 | Sell |
| 20-day EMA: | 0.04 | Sell |
| 50-day EMA: | 0.05 | Sell |
| 200-day EMA: | 0.1 | Sell |
DRUG.CX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 59.38 | Sell |
| 20-day SMA: | 55.63 | Sell |
| 50-day SMA: | 49.57 | Buy |
| 200-day SMA: | 13.56 | Buy |
| 8-day EMA: | 56.46 | Sell |
| 20-day EMA: | 56.55 | Sell |
| 50-day EMA: | 47.73 | Buy |
| 200-day EMA: | 21.33 | Buy |
4Front Ventures Earnings Growth & FFNT.CX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and a decrease next year of $0.00 per share.
Bright Minds Biosciences Earnings Growth & DRUG.CX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.53 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $4.02 per share.
4Front Ventures Technical Analysis
| Nov 27 | Nov 28 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 28 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences Technical Analysis
| Nov 27 | Nov 28 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 28 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||